Reprint

Diseases of the Salivary Glands—Part II

Edited by
October 2022
152 pages
  • ISBN978-3-0365-5567-6 (Hardback)
  • ISBN978-3-0365-5568-3 (PDF)

This is a Reprint of the Special Issue Diseases of the Salivary Glands—Part II that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

The year 2021 saw the publication of the Special Issue “"Diseases of the Salivary Glands" (https://www.mdpi.com/journal/jcm/special_issues/Salivary_Glands), Part I, covering recent and novel advancements as well as future trends in the field of research evaluating diagnostic and therapeutic treatment of salivary gland (SGs) diseases.

Given the enormous success of Part I, the Special Issue “Diseases of the Salivary Glands” Part II has been launched, with the firm belief that it will enrich the panorama of world research in this field.

Topics include:

1) Clinical features and presentation of potentially malignant SG disorders;

2) Risk factors and etiopathogenesis of SGs tumors;

3) Etiopathogenesis and molecular mechanisms involved in the chronic inflammatory condition characterizing Sjӧgren’s syndrome;

4) New discoveries in the field of micro RNAs associated with Sjӧgren’s syndrome;

5) Molecular markers linked to development and progression of SG diseases: current knowledge and future implications;

6) More innovative techniques for the study of the SG diseases: current limitations and future directions.

Format
  • Hardback
License and Copyright
© 2022 by the authors; CC BY-NC-ND license
Keywords
xerostomia; dry mouth; protein–protein interaction; drug target; head and neck cancer; Sjögren’s Syndrome; major histocompatibility complex (MHC); human leukocyte antigen (HLA); autoantigens; T cells; E-cadherins; salivary glands; morphogenesis; EMT; Sjögren’s syndrome; autoimmunity; hydrogen peroxide; adrenaline; blood loss; tonsillectomy; salivary glands; fibrosis; EMT; Sjögren’s syndrome; autoimmunity; pleomorphic adenoma; epithelial–mesenchymal transition; carcinoma ex-pleomorphic adenoma; Sjögren’s syndrome; 99mTc-interleukin-2; activated lymphocytes; salivary glands; inflammation imaging; Sjögren syndrome; nuclear medicine; radiopharmaceuticals; PET; SPECT; EMT; Sjögren’s syndrome; Follistatin-like 1 protein; TGF-β1; SMAD2/3; fluoride; sodium fluoride; salivary glands; n/a

Related Books